Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Vortioxetine
Takeda
Schizophrenia
1 trial -
Vortioxetine 10 mg
Takeda
Age-related Cognitive Decline
1 trial -
Vyndaqel 61 mg soft capsules
Monte Rosa Therapeutics
Transthyretin cardiac amyloidosis
1 trial -
Vyvanse (lisdexamfetamine dimesylate)
Takeda
Attention Deficit Hyperactivity Disorder (ADHD)
1 trial -
Vyvgart 20 mg/mL concentrate for solution for infusion
The George Institute
Patients affected by generalized myasthenia gravis
1 trial -
Wangbi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
Warfarin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anticoagulation
1 trial -
Web-based smoking cessation program
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Wegovy 2.4 mg solution for injection in pre-filled pen
The George Institute
obstructive sleep apnea
1 trial -
Wegovy FlexTouch solution for injection in pr... for Adipositas
Lacuna Pharma Pty Ltd
Adipositas
1 trial -
Wen Xin granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
XELJANZ 11 mg prolonged-release tablets
Disc Medicine
Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria
1 trial -
XR-B (SUBLOCADETM)
BRIGHT MINDS BIOSCIENCES INC.
Opioid-use Disorder
1 trial -
Xiang Sha Liu Jun Zi Decoction dry powder
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
Xingnaojing injection
Universal Integrated
Acute Ischemic Stroke
1 trial -
Xingnaojing injection
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
1 trial -
Xingnaojing injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Xinnaoning Capsule
BRIGHT MINDS BIOSCIENCES INC.
Chronic Stable Angina Pectoris
1 trial -
Xolair
United Therapeutics Europe Ltd
Atopic Eczema
1 trial -
Xolair 75 mg solution for injection in pre-filled syringe
Pari Pharma GmbH
Well controlled severe allergic asthma
1 trial -
Xtampza ER (oxycodone)
COLLEGIUM PHARMACEUTICAL, INC
Chronic Pain
1 trial -
Xtandi - 40 mg soft capsules
The George Institute
PROSTATE CANCER
1 trial -
Xuebijing
Rocket Pharmaceuticals B.V.
Pulmonary Disease, Chronic Obstructive
1 trial -
Xuebijing Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
2 trials -
Xuesaitong Soft Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
2 trials -
Xueshuanxinmaining tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Xyrem (X)
Jazz Pharmaceuticals Ireland Limited
Obstructive Sleep Apnea Syndrome
1 trial -
Yiqitongluo granule
The First People's Hospital of Lianyungang
Stroke
1 trial -
Yuflyma solution for injection in pre-filled pen for Rheumatoid arthritis
Lacuna Pharma Pty Ltd
Rheumatoid arthritis
1 trial -
Z-Brace interbody fusion device
Hospital Authority, Hong Kong
Cervical Disc Degeneration
1 trial -
ZULRESSO®
SUPERNUS PHARMACEUTICALS, INC.
Postpartum Depression
1 trial -
ZYNRELEF 200Mg-6Mg Extended-Release Solution
Heron Therapeutics
Post Operative Pain, Acute
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Waldenström's Macroglobulinemia
1 trial -
Zavicefta, Ceftazidime-Avibactam
Pfizer
Hospital-Acquired Pneumonia
1 trial -
Zeposia 0.92 mg hard capsules
Verona Pharma Ireland Limited
Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)
1 trial -
Zhenyuan capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stable Coronary Heart Disease
1 trial -
Zithromax
United Therapeutics Europe Ltd
Asthma
1 trial -
Zoledronate
United Therapeutics Europe Ltd
Hip Fractures
1 trial -
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
Zushima plaster with high dose
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
[68Ga]FAPI-46
Disc Medicine
post-acute sequelae of COVID-19
1 trial -
[68Ga]FAPI-46
Disc Medicine
Non-resolving ARDS
1 trial -
[68Ga]FAPI-46
Disc Medicine
Peyronie's Disease
1 trial -
a control group
The First People's Hospital of Lianyungang
Disorder of Stomach Function and Feeding Problems in Newborn
1 trial -
adefovir dipivoxil
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
aflibercept 2.0 mg
Regeneron UK Limited
Age Related Macular Degeneration
1 trial -
aflibercept 2.0 mg
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
albumin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.